Scientific Reports in Nature has published the breakthrough results of our in depth research conducted at the University of Lausanne, Switzerland’s CHUV hospital by Professor Patrick Schoettker.
Focusing on optical blood pressure sensing using only the fingertip on a smartphone camera, the study demonstrated that our OptiBP™ software has achieved equivalency with the traditional blood pressure cuff performance and the ISO 81060-2 standard, representing no less than a revolution in how we measure and manage high blood pressure.
In the new world of (now essential) remote patient monitoring, especially in
light of the Covid-19 pandemic, Biospectal’s OptiBP™ smartphone app and connected data platform enable clinical grade blood pressure management at the “point of patient” without any bulky extra device.
OptiBP™ enables better patient driven tracking of blood pressure and integration with the standard of care. Our real goal is improved health, length, and quality of life. With our software solution, anyone worldwide with a smartphone nearly instantly can now have a connected, smart, clinical grade monitor in the time it takes to download and install an app.
The Research Study can be downloaded below and accessed online at https://lnkd.in/gKZpGxK.
The study in PDF format can be downloaded here.
A) Wenn and where will it be available
B) Can the app operate whitout net connection?
The app is currently in public beta, you can sign up via our web site. We can’t reveal when exactly we are going to release the full commercial version, but it is effectively mature at this point. And yes, the app works offline with sync to the cloud when connected. Thanks!
Ich interessiere mich für dieses App da ich einer
Gefäserkrankung leide und
gefärdet bin bei Bluthochdruck.
Hi Daniel, senden Sie uns Eure Kontaktinformation by email@example.com oder https://biospectal.com/optibp-beta-sign-up/
Do you have CE Certification for this product? If not, are you planning to apply for it and when do you think you will have it?
Hi Sarah, reach out to us directly at firstname.lastname@example.org and we can discuss further, thanks!
Comments are closed.